Operating profit before deduction of amortization: Ventyx Biosciences, Inc. (VTYX)
Ventyx Biosciences (VTYX) operates independently of GDP cycles, although it relies on third-party CMO capacities for drug production. Historical EBITDA_Co data demonstrate the company's cash resilience, with 0.00 serving as the current value of the metric. Market capitalization is expected to grow through the development of convenient tablet medications for psoriasis patients, which will be in high demand by insurance companies.
Ventyx Biosciences, Inc. (VTYX) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio Ventyx Biosciences|VTYX - Long-Term Debt to Capital|Current Liabilities to Capital Ventyx Biosciences Inc.|VTYX - Company Total Debt|Debt to Book Capitalization Ratio Ventyx Biosciences|VTYX - Company Long-Term Debts|Short-Term Debt Ventyx Biosciences|Immediate Liquidity Ratio ventyxbio.com
- earnings and multiples data:
VTYX - Net Income|Future Net Profit Ventyx Biosciences|VTYX - Price to Earnings Ratio|Projected Price to Earnings Ratio ventyxbio.com|VTYX - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ventyx Biosciences|VTYX - Operating profit before deduction of amortization|Earnings per share for the trailing year Ventyx Biosciences|VTYX - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months ventyxbio.com|VTYX - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Ventyx Biosciences
Fundamental company valuation:Ventyx Biosciences, Inc (VTYX)
To assess the fundamental quality of Ventyx Biosciences (VTYX), an investor must analyze the daily cash flow from operating activities, excluding non-cash charges. This aggregate EBITDA reflects the business's actual liquidity, where the stability of the metrics on this chart confirms the company's ability to fund small molecule clinical trials and maintain strategic potential for M&A transactions.
Who Ventyx Biosciences competes with
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|adaptivebiotech.com - Operating profit before amortization|Operating profit EBITDA CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Profit before interest, taxes and amortization|BCRX: Operating profit before deduction of amortization|VERA: Profit before payment of interest, taxes and amortization|DNTH: Operating profit EBITDA|Profit before interest, taxes and amortization pharvaris.com (PHVS)|Profit before payment of interest, taxes and amortization AbCellera Biologics Inc.|Operating profit before amortization TRML (Tourmaline Bio Inc)|Operating profit before deduction of amortization PGEN (Intrexon)|Company profit before taxes, interest and amortization PHAR|Nektar Therapeutics - Operating profit before deduction of amortization|upstreambio.com (UPB) - Profit before interest, taxes and amortization|ZBIO: Operating profit before deduction of amortization|IMNM (Immunome Inc) - Operating profit before amortization|GOSS (Gossamer Corp) - Operating profit before deduction of amortization|KalVista Corp - Income before deduction of interest, taxes and amortization|SEPN (Septerna Inc) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization PVLA|Operating profit EBITDA SVRA|Operating income before deduction of amortization Rigel Pharma|Profit before payment of interest, taxes and amortization AnaptysBio Corp ANAB|Astria Corp (ATXS) - Profit before interest, taxes and amortization|ENGN - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization RAPT Therapeutics Inc. RAPT|JBIO: Operating profit EBITDA|Operating profit before deduction of amortization Aclaris Therapeutics Inc.|KYTX (Kyverna) - Operating profit EBITDA|Tiziana Life Sciences, Ltd. (TLSA) - Operating income before deduction of amortization|Operating profit EBITDA CABA|THTX - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Avalo Therapeutics AVTX|ELDN: Operating profit before amortization|Agenus Inc - Operating profit EBITDA|Climb Bio, Inc (CLYM) - Operating profit before deduction of amortization|ZURA: Operating profit EBITDA|Profit before interest, taxes and amortization atyrpharma.com (ATYR)|Profit before payment of interest, taxes and amortization Adagene Inc|Ikena Oncology, Inc. (IMA) - Operating income before deduction of amortization|Operating profit before deduction of amortization STTK (Shattuck Labs, Inc.)|Profit before payment of interest, taxes and amortization EQ (equilliumbio.com)|Connect Biopharma Holdings Limited - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization IMUX (Immunic Therapeutics)|ATRA: Operating profit before deduction of amortization|Profit before interest, taxes and amortization InflaRx N.V.|XFOR (X4 Pharma) - Operating profit before deduction of amortization|Operating profit before amortization ACET|Profit before payment of interest, taxes and amortization Celularity Inc|inmunebio.com - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA BRNS|KZR (Kezar Life Sciences Inc.) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA SABS (SAB Biotherapeutics, Inc)|Operating profit EBITDA Akari Therapeutics, Plc AKTX|ENLV - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization QTTB (Q32 Bio Inc.)|GeoVax (GOVX) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Edesa Biotech Inc|IBIO (iBio Corp) - Operating profit EBITDA|Operating profit EBITDA Carisma Tx|Operating profit before deduction of amortization XTLB (XTL Biopharmaceuticals)|BOLT (boltbio.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA HCWB (HCW Biologics)|Operating income before deduction of amortization Aptevo Therapeutics, Inc. (APVO)|AIM - Profit before payment of interest, taxes and amortization|Aditxt (ADTX) - Operating profit before deduction of amortization|GRI Bio, Inc. (GRI) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization xortx.com|Operating profit before deduction of amortization HIND|Operating profit EBITDA Revelation Biosciences Inc|Profit before payment of interest, taxes and amortization Indaptus (INDP)|BiondVax Pharmaceuticals - Operating profit before amortization|Operating profit EBITDA CALI (CalciMedica)|Affimed NV (AFMD) - Profit before interest, taxes and amortization|ALLK: Operating profit before deduction of amortization|HOOK: Profit before payment of interest, taxes and amortization|IGMS: Operating profit EBITDA|Profit before interest, taxes and amortization iTeos Pharma (ITOS)|Profit before payment of interest, taxes and amortization Ocean Biomedical, Inc.|Operating profit before amortization TCBP (tcbiopharm.com)|Operating profit before deduction of amortization THRD (Third Harmonic Bio, Inc.)
